Novo Nordisk Stock Decline - Search News

News

CEO of Novo Nordisk, maker of weight loss drug Wegovy

The New York Times · 3d

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

CNBC on MSN · 18h

Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and navigate other challenges

Barron's on MSN · 3d

Novo Nordisk Boots CEO After Stock Falls 50%. It’s an Unusual Move for the Wegovy Drugmaker.

It was a ‘mutual agreement,’ Novo says in a statement. A search for Fruergaard Jørgensen’s successor is ongoing.

3d

Novo Nordisk Stock: Seems Like A No-Brainer At These Levels

Discover why Novo Nordisk A/S' undervalued shares present a buying opportunity, with strong sales growth, profitability, and ...

3don MSN

Novo Nordisk CEO steps down as Wegovy maker faces increased competition

As Novo Nordisk's share price drops, CEO Lars Fruergaard Jorgensen steps down. The company aims to maintain its lead in the ...

Zacks Investment Research on MSN3d

Novo Nordisk Stock Gains 14% in a Month: What Should Investors Do?

Novo Nordisk NVO shares have gained 13.9% in the past month. Several factors related to the company’s pipeline, regulatory ...

3d

Ozempic-Maker CEO Ousted Over Pharma Company’s Rocky Market Downturn

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

5d

Ignore The Noise - Novo Nordisk Is A Clear Buy

Novo Nordisk's current product portfolio is well-protected by patents until at least 2030. Click here to see why NVO stock is ...

13d

Stock Movers: Novo Nordisk, Maersk, BMW

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results